Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 90 days matching "new medicines"

Drug approvalEMAYesterday

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2026

The European Medicines Agency approved eight new medicines in May 2026. The article mentions a few specific drugs, including Jascayd (nerandomilast) and Boey (trenibotulinumtoxinE), though details about what diseases they treat are incomplete in this announcement.

WHY IT MATTERSIf you have a rare disease, one of these eight newly approved medicines might be a treatment option available in Europe — check with your doctor to see if any match your condition.
💬 Ask your doctor
Drug approvalEMAMay 11

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 April 2026

The European Medicines Agency's committee met in April 2026 and recommended five new medicines for approval in Europe. One of these medicines is called Cenrifki (tolebrutinib), though the article doesn't provide complete details about what diseases these medicines treat. This is a routine announcement about medicines moving forward in the approval process.

WHY IT MATTERSIf you or a loved one has a condition treated by one of these five newly recommended medicines, approval in Europe may mean the drug becomes available sooner in your country, though availability timelines vary by nation.
👁 Watch this space

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases